Biotech Digest – SGMO Announces Strong Quarterly Numbers, APEN Receives FDA Alert, CELG Modifies Collaboration

Sangamo Therapeutics shot up as the company announced better than expected quarterly numbers. Celgene announced modifying its collaboration with Sutro. Aethlon Medical reported that its net loss for the June 2017 quarter was $1.8 million.